🌟 What is the consensus among analysts for IPA's short-term price movement?

The consensus among analysts for IPA's (ImmunoPrecise Antibodies Ltd.) short-term price movement is positive. Here's a detailed analysis:

1. **Analyst Ratings**:
- IPA has a consensus rating of "Buy" among analysts, with two out of two analysts recommending it.
- The "Buy" rating reflects analysts' optimism about the company's future performance and potential for growth.
2. **Price Target Range**:
- The average price target set by analysts for IPA is $4.00, with a high forecast of $5.00 and a low forecast of $3.00.
- This range suggests that analysts believe the stock has potential to increase in value from its current price.
3. **Upside Potential**:
- The average price target represents a forecasted upside of 100.00% from the current price of $2.00.
- This indicates that analysts see significant potential for the stock to appreciate in value in the short term.
4. **Market Sentiment**:
- Despite the positive analyst ratings, the stock has experienced volatility, with a recent decline of -1.20%.
- However, the overall sentiment among analysts remains positive, with a focus on the company's growth prospects and pipeline advancements.

In conclusion, the consensus among analysts for IPA's short-term price movement is positive, with potential for significant upside based on the average price target and analyst ratings. However, investors should monitor the company's performance closely and consider other factors before making investment decisions.